Future Oncology is celebrating its tenth anniversary by publishing a Special Focus issue documenting the past, present and future of several cancers. Such is the extent of the progress seen in all fields of oncology since the journal's debut in 2005, that authors were invited to document these advancements in the issue, with speculation as to how further progress will be made in the coming years. The journal is published by Future Medicine, an imprint of Future Science Group.
"This issue marks the 10th Anniversary of Future Oncology, a dynamic cancer journal highlighting the progress of various areas in oncology," commented Simon Lo, a member of the Future Oncology Editorial Board and contributor to the issue. "The journal is at the forefront of reporting and addressing the most important clinical and scientific issues as well as research findings in oncology."
The issue includes several review articles from renowned authors, covering areas such as: immunotherapy for non-small cell lung cancer, the development of stereotactic body radiotherapy, personalized therapy for colorectal cancer and fertility preservation in cancer patients. Editorial articles include coverage of image-guided brachytherapy in cervical cancer, metastatic gastric cancer and the role of chemotherapy in prostate cancer.
"We are excited to be publishing this Special Focus issue of Future Oncology, which includes a number of comprehensive review articles from diverse oncology specialties," commented Nick Ward, Commissioning Editor of Future Oncology. "The issue aims to highlight and celebrate the vast progress made in several research areas and provide a future outlook on how the field will evolve."
To read the full issue, please click here
Additional articles and cancer content can be found on Oncology Central, Future Science Group's free eCommunity for oncology professionals. The membership-based portal offers free access to breaking oncology news and peer-reviewed journal articles, with content selected by fellow clinicians.
About Future Oncology
Future Oncology is a MEDLINE-indexed journal, with an impact factor of 2.477. The journal covers the latest scientific and clinical issues, together with the economic and policy issues of relevance to oncologists. The journal delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.